Position in GERN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$643,683
+$12,925 QoQ
Shares Held
502,878
+18.8% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#70
of 259 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Mar 31, 2026CallValue
$655
CallShares
4,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $44,247,243 across 48 Biotechnology names. GERN ranks #13 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,557 | $11,571,031 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
111,129 | $6,060,975 | |
| 3 | CRMD |
CorMedix Inc.
|
415,406 | $3,260,937 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
30,352 | $2,473,991 | |
| 5 | TLX |
Telix Pharmaceuticals Ltd
|
197,250 | $2,274,292 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,130 | $2,051,494 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
165,954 | $1,452,927 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
504,000 | $1,305,360 |
All Filings in GERN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $643,683 | 502,878 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $655 | 4,500 | Call | Sole | 2026-04-27 | |
| 2026-03-31 | $630,758 | 423,328 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $260 | 8,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $554,838 | 420,332 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $573,861 | 418,877 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $489,958 | 347,488 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $538,369 | 338,597 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $591,703 | 167,148 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $763,505 | 168,173 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $759,672 | 179,168 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $599,118 | 181,551 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $740,913 | 351,144 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $736,882 | 347,586 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $975,840 | 304,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $433,783 | 199,900 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $132,253 | 54,650 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $81,081 | 34,650 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $49,832 | 32,150 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $17,598 | 12,940 | Shares | Sole | 2022-05-12 | |
| 2021-03-31 | $24,174 | 15,300 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $21,067 | 13,250 | Shares | Sole | 2021-04-01 | |
| 2020-09-30 | $29,319 | 16,850 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $36,733 | 16,850 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $19,525 | 16,408 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||